These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 5692873)

  • 1. Failure of natural stimuli to accelerate brain catecholamine depletion after biosynthesis inhibiton with alpha-methyltyrosine.
    Welch AS; Welch BL
    Brain Res; 1968 Jul; 9(2):402-5. PubMed ID: 5692873
    [No Abstract]   [Full Text] [Related]  

  • 2. The combined use of alpha-methyltyrosine and threo-dihydroxyphenylserine--selective reduction of dopamine levels in the central nervous system.
    Creveling CR; Daly J; Tokuyama T; Witkop B
    Biochem Pharmacol; 1968 Jan; 17(1):65-70. PubMed ID: 5638559
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of morphine intoxication on brain catecholamine neurons.
    Gunne LM; Jonsson J; Fuxe K
    Eur J Pharmacol; 1969 Mar; 5(4):338-42. PubMed ID: 4306742
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of catecholamine synthesis during ontogenic development.
    Kellogg C; Lundborg P
    Brain Res; 1973 Oct; 61():321-9. PubMed ID: 4149305
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute effects of alpha-methyltyrosine on brain catecholamine levels and on spontaneous and amphetamine-stimulated motor activity in mice.
    Dominic JA; Moore KE
    Arch Int Pharmacodyn Ther; 1969 Mar; 178(1):166-76. PubMed ID: 5353469
    [No Abstract]   [Full Text] [Related]  

  • 6. Alterations in behavior and brain catecholamine levels in rats treated with alpha-methyltyrosine.
    Rech RH; Borys HK; Moore KE
    J Pharmacol Exp Ther; 1966 Sep; 153(3):412-9. PubMed ID: 5922318
    [No Abstract]   [Full Text] [Related]  

  • 7. Antagonism by monoamine oxidase inhibitors of alpha-methyltyrosine-induced catecholamine depletion and behavioral depression.
    Moore KE; Rech RH
    J Pharmacol Exp Ther; 1967 Apr; 156(1):70-5. PubMed ID: 6023602
    [No Abstract]   [Full Text] [Related]  

  • 8. Specific antagonism by dopamine inhibitors of items of amphetamine induced aggressive behaviour.
    Hasselager E; Rolinski Z; Randrup A
    Psychopharmacologia; 1972; 24(4):485-95. PubMed ID: 5064290
    [No Abstract]   [Full Text] [Related]  

  • 9. Alpha-methyl-p-tyrosine and memory: state-dependency and memory failure.
    Zornetzer SF; Gold MS; Hendrickson J
    Behav Biol; 1974 Sep; 12(1):135-41. PubMed ID: 4429509
    [No Abstract]   [Full Text] [Related]  

  • 10. Behavioral correlation of catecholamine concentration and turnover in discrete brain areas of three strains of mice.
    Tizabi Y; Thoa NB; Maengwyn-Davies GD; Kopin IJ; Jacobowitz DM
    Brain Res; 1979 Apr; 166(1):199-205. PubMed ID: 570440
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of isolation and fighting in mice on the rate of synthesis of noradrenaline, dopamine and 5-hydroxytryptamine in the brain.
    Modigh K
    Psychopharmacologia; 1973 Oct; 33(1):1-17. PubMed ID: 4797645
    [No Abstract]   [Full Text] [Related]  

  • 12. The identification of specific brain nuclei in which catecholamine turnover is increased by left ventricular receptors during acute myocardial infarction in the rat.
    Sole MJ; Hussain MN; Versteeg DH; de Kloet ER; Adams D; Lixfeld W
    Brain Res; 1982 Mar; 235(2):315-25. PubMed ID: 7188330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The brain catecholamine systems in the regulation of dominance].
    Serova LI; Naumenko EV
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1990; 40(3):490-6. PubMed ID: 1975967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral effects of alpha-methyltyrosine after prior depletion of brain catecholamines.
    Rech RH; Carr LA; Moore KE
    J Pharmacol Exp Ther; 1968 Apr; 160(2):326-35. PubMed ID: 5651375
    [No Abstract]   [Full Text] [Related]  

  • 15. Potentiation of suckling-induced release of prolactin by inhibition of brain catecholamine synthesis.
    Voogt JL; Carr LA
    Endocrinology; 1975 Oct; 97(4):891-7. PubMed ID: 1193011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lidocaine's influence on the accumulation and depletion rates of mouse brain amines.
    Ciarlone AE; Smudski JW
    J Dent Res; 1977 Nov; 56(11):1391-4. PubMed ID: 274465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain and testicular function.
    Bliss EL; Frischat A; Samuels L
    Life Sci I; 1972 Mar; 11(5):231-8. PubMed ID: 4265820
    [No Abstract]   [Full Text] [Related]  

  • 18. Evidence for involvement of brain dopamine and other mechanisms in the behavioral action of the N-methyl-D-aspartic acid antagonist MK-801 in control and 6-hydroxydopamine-lesioned rats.
    Criswell HE; Johnson KB; Mueller RA; Breese GR
    J Pharmacol Exp Ther; 1993 May; 265(2):1001-10. PubMed ID: 8098756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of 3-OM-dopa on monoamine metabolism in rat brain.
    Gervas JJ; Muradás V; Bazán E; Aguado EG; de Yébenes JG
    Neurology; 1983 Mar; 33(3):278-82. PubMed ID: 6681870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of norepinephrine depletion by 5-hydroxytryptophan.
    Johnson GA; Kim EG; Boukma SJ
    Proc Soc Exp Biol Med; 1968 Jun; 128(2):509-12. PubMed ID: 5302002
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.